NewOrganic ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  17.1% 17.1% 18.4% 13.9% 14.2%  
Credit score (0-100)  9 9 7 15 15  
Credit rating  BB BB B BB BB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  41.0 -46.2 51.7 99.4 270  
EBITDA  41.0 -46.2 51.7 99.4 270  
EBIT  26.9 -54.3 51.7 99.4 270  
Pre-tax profit (PTP)  5.3 -54.6 41.6 99.4 268.0  
Net earnings  -18.5 -42.4 32.1 77.5 212.2  
Pre-tax profit without non-rec. items  5.3 -54.6 41.6 99.4 268  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  8.1 0.0 0.0 0.0 0.0  
Shareholders equity total  -221 -233 -201 -124 87.8  
Interest-bearing liabilities  0.0 0.0 0.0 29.6 186  
Balance sheet total (assets)  385 587 518 309 559  

Net Debt  -28.6 -25.9 -40.4 15.3 -69.2  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  41.0 -46.2 51.7 99.4 270  
Gross profit growth  0.0% 0.0% 0.0% 92.2% 171.5%  
Employees  0 0 0 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  385 587 518 309 559  
Balance sheet change%  17.3% 52.7% -11.8% -40.3% 80.6%  
Added value  41.0 -46.2 51.7 99.4 269.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -28 -16 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 1.0 2.0 3.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  65.6% 117.6% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  4.8% -7.6% 6.7% 17.2% 54.4%  
ROI %  5.3% -12.9% 22.0% 100.0% 178.1%  
ROE %  -5.2% -8.7% 5.8% 18.7% 106.9%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  -36.5% -28.4% -28.0% -28.7% 15.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -69.7% 56.2% -78.1% 15.4% -25.6%  
Gearing %  0.0% 0.0% 0.0% -23.8% 211.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.1% 1.7%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.6 0.2 0.2 0.2 0.7  
Current Ratio  5.2 1.1 0.9 0.7 1.2  
Cash and cash equivalent  28.6 25.9 40.4 14.4 254.8  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  278.2 34.0 -67.7 -124.5 87.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 99 270  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 99 270  
EBIT / employee  0 0 0 99 270  
Net earnings / employee  0 0 0 78 212